Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

The objective of the study was to use CD146 mRNA to predict the evolution of patients with non-metastatic clear cell renal cell carcinoma (M0 ccRCC) towards metastatic disease, and to use soluble CD146 (sCD146) to anticipate relapses on reference treatments by sunitinib or bevacizumab in patients wi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Theranostics
Autors principals: Dufies, Maeva, Nollet, Marie, Ambrosetti, Damien, Traboulsi, Wael, Viotti, Julien, Borchiellini, Delphine, Grépin, Renaud, Parola, Julien, Giuliano, Sandy, Helley-Russick, Dominique, Bensalah, Karim, Ravaud, Alain, Bernhard, Jean-Christophe, Schiappa, Renaud, Bardin, Nathalie, Dignat-George, Françoise, Rioux-Leclercq, Nathalie, Oudard, Stephane, Négrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Blot-Chabaud, Marcel, Pagès, Gilles
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928901/
https://ncbi.nlm.nih.gov/pubmed/29721091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.23002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars